JCR PHARMACEUTICALS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 648 JPY | -18.80% |
|
-19.60% | -44.71% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 | 42.87B 275M | Sales 2025 * | 42.54B 273M | Capitalization | 99.59B 639M |
|---|---|---|---|---|---|
| Net income 2024 | 5.51B 35.32M | Net income 2025 * | 6.42B 41.18M | EV / Sales 2024 | 2.5 x |
| Net Debt 2024 * | 12.66B 81.19M | Net Debt 2025 * | 14.05B 90.11M | EV / Sales 2025 * | 2.67 x |
| P/E ratio 2024 |
19.5
x | P/E ratio 2025 * |
15.5
x | Employees | 879 |
| Yield 2024 |
2.33% | Yield 2025 * |
2.51% | Free-Float | 52.97% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -18.80% | ||
| 1 week | -19.60% | ||
| Current month | -20.49% | ||
| 1 month | -21.36% | ||
| 3 months | -34.41% | ||
| 6 months | -46.53% | ||
| Current year | -44.71% |
1 week
648.00
814.00
1 month
648.00827.00
Current year
648.001 228.00
1 year
648.001 567.00
3 years
648.003 745.00
5 years
648.003 800.00
10 years
440.253 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 03-03-31 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 18-06-26 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.67% | 0 M€ | +3.37% | - | |
| 0.30% | 0 M€ | +11.51% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 648 | -18.80% | 3 087 800 |
| 24-05-10 | 798 | -0.13% | 546,400 |
| 24-05-09 | 799 | -0.12% | 288,800 |
| 24-05-08 | 800 | -0.74% | 375,800 |
Delayed Quote Japan Exchange, May 13, 2024 at 02:00 am EDT
More quotes
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
Sector
Pharmaceuticals
Calendar
2024-07-24
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
798
JPY
Average target price
1,464
JPY
Spread / Average Target
+83.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -44.71% | 639M | |
| +30.38% | 684B | |
| +29.45% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.51% | 240B | |
| +8.91% | 208B | |
| -8.02% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- 4552 Stock
